Page last updated: 2024-11-06

hydroxyproline and Myasthenia Gravis

hydroxyproline has been researched along with Myasthenia Gravis in 1 studies

Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.

Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KIBRICK, AC1
HASHIRO, C1
WALTERS, M1
MILHORAT, AT1

Other Studies

1 other study available for hydroxyproline and Myasthenia Gravis

ArticleYear
HYDROXYPROLINE EXCRETION IN URINE OF PATIENTS WITH MUSCULAR DYSTROPHY AND OTHER MUSCLE DISEASES.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1964, Volume: 115

    Topics: Adolescent; Amyotrophic Lateral Sclerosis; Child; Creatine; Creatinine; Dermatomyositis; Humans; Hyd

1964